<DOC>
	<DOCNO>NCT03015831</DOCNO>
	<brief_summary>The prior End-AF study group show 1 mg colchicine n't decrease incidence AF cardiac surgery . The current study , End-AF Low Dose Study , test 0.5 mg colchicine vs. placebo prevent AF cardiac surgery .</brief_summary>
	<brief_title>Effect Low Dose ColchiciNe InciDence POAF</brief_title>
	<detailed_description>AF cardiac surgery lead excess mortality morbidity . Colchicine use several study low incidence AF result generally disappoint . There benefit reduce AF high incidence GI side effect especially diarrhea , often lead stop medication . However , recently publish meta-analysis show colchicine reduce AF , warn high incidence GI side effect . The maintenance dose colchicine use study 1 mg daily hypothesize low dose colchicine ( 0.5 1 mg colchicine ) might lower AF cardiac surgery without prohibitive GI side effect Patients randomized colchicine vs. placebo start day surgery continue hospital discharge . The primary efficacy endpoint incidence AF . The primary safety endpoint GI side effect</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>All patient age 18 year undergoing elective cardiac surgery . Sinus rhythm previous AF Agreed sign inform consent . Known severe liver disease current transaminases &gt; 1.5 time upper normal limit Current serum creatinine &gt; 2.5 mg/dL Known myopathy elevate baseline preoperative creatine kinase Known blood dyscrasia significant gastrointestinal disease Pregnant lactate woman Known hypersensitivity colchicine Current treatment colchicine indication Emergency surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Colchicine</keyword>
</DOC>